Oncology

Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

Jean-Yves Douillard
Jean-Yves Douillard
Gordon McVie
Gordon McVie

REFERENCE: Abstracts: 6507 & 2LB, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
JEAN-YVES DOUILLARD, Centre René Gauducheau, Nante
COMMENT: GORDON MCVIE, European Institute of Oncology, Milan

The vinca alkaloid vinflunine and the tyrosine kinase inhibitor gefitinib both achieved equivalent benefits to standard docetaxel second-line therapy among patients with advanced or metastatic non-small cell lung cancer previously treated with platinum.

John Crown
John Crown

Lapatinib Adds Benefit to Capecitabine in Metastatic Breast Cancer

REFERENCE: Abstract: 2096, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
JOHN CROWN, St Vincent’s University Hospital, Dublin
In heavily pre-treated metastatic breast cancer, lapatinib has been confirmed to add a benefit to capecitabine, according to updated efficacy data presented in Barcelona. The implication is that gene profiles from some breast tumors could help pinpoint which patients might do best on lapatinib.

Rob Tollenaar
Rob Tollenaar
Gordon McVie
Gordon McVie

Gene Profile to Improve Recommendations in Stage II Colon Cancer?

REFERENCE: Abstract: 3007, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
ROB TOLLENAAR, Leiden University Medical Center
COMMENT: GORDON MCVIE, European Institute of Oncology, Milan

The ECCO conference heard that a gene expression profile could help doctors easily identify patients with stage II colon cancer who need chemotherapy after surgery, and might be better at selecting patients for chemotherapy than the current ASCO guidelines.

To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations.

Similar Interviews

  • When Good Cells Go Bad: The Stem Cell Origin of Cancers
  • DAVID JABLONS, University of California, San Francisco REFERENCE: Keynote Lecture, Perspectives in Lung Cancer Conference, 2-3 March 2007, Seville, Spain Cell signalling

  • Audio Journal of Oncology in Advance - April 15th, 2007 - Bisphosphonates Recommended for Lung Cancer Bone Metastases
  • PETER HARPER, Guy’s Hospital, London REFERENCE: “Management of Tumour and Treatment Related Symptoms” section, Perspectives in Lung Cancer, Seville Bisphosphonates may be

  • Audio Journal of Oncology in Advance - January 15th, 2007 - HERA Study Results Confirm Trastuzumab Benefit in HER2 Positive Early Breast Cancer
  • IAN SMITH, Royal Marsden Hospital, London REFERENCE: Lancet 369:29 Confirmation of the life-extending benefits of trastuzumab adjuvant therapy for early breast

    Post a comment

    Subscribe to Audio Medica Podcast